Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Mebendazole Use. [PDF]
Basic Clin Pharmacol ToxicolHeerfordt IM +4 more
europepmc +1 more source
Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: A review of current management and changing trends. [PDF]
Indian J OphthalmolAkgun Z, Can GD, Selver OB.
europepmc +1 more source
Suspected Stevens-Johnson Syndrome After Azithromycin and Doxycycline Exposure in an Elderly Woman: A Case Report Showcasing Treatment Based on Clinical Diagnosis. [PDF]
CureusBaskaran M, Kim A, Grana W.
europepmc +1 more source
Stevens-Johnson syndrome/toxic epidermal necrolysis induced by tislelizumab: a case report and literature review. [PDF]
Front ImmunolYu H, Li Y, Qu X, Zhu J, Liu Z, Mu Z.
europepmc +1 more source
Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel. [PDF]
, 2005 Bailey, MS +7 more
core +1 more source
Fatal Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Advanced Lung Adenocarcinoma. [PDF]
Kaohsiung J Med SciChang PC, Chang TW, Kuo CY, Wu YZ.
europepmc +1 more source
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Ophthalmic Management and Treatment. [PDF]
Vision (Basel)Sawires K +6 more
europepmc +1 more source
Summary of the Best Evidence on Skin-Mucosal Care in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. [PDF]
Adv Skin Wound CareLei Y +5 more
europepmc +1 more source
Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: age-stratified insights from the FAERS database. [PDF]
J Pediatr (Rio J)Bayram-Ozgur D +5 more
europepmc +1 more source
Immune checkpoint inhibitor-related Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective analysis of 21 cases. [PDF]
Front ImmunolPu T, Teng Y, Zhang Y, Da M, Wang F.
europepmc +1 more source